Colgate-Palmolive Tidigare resultatutveckling
Tidigare kriterier kontrolleras 1/6
Colgate-Palmolive har ökat intäkterna med en genomsnittlig årlig takt på 3.2%, medan Household Products -branschen såg intäkterna växer på 1.7% årligen. Intäkterna har varit växande med en genomsnittlig takt på 4.4% per år. Colgate-Palmolive s avkastning på eget kapital är 619.5% och den har en nettomarginal på 10.5%.
Viktig information
3.25%
Tillväxttakt i vinsten
4.48%
Tillväxttakt för EPS
| Household Products Tillväxt i branschen | 1.51% |
| Intäkternas tillväxttakt | 4.43% |
| Avkastning på eget kapital | 619.45% |
| Nettomarginal | 10.46% |
| Nästa resultatuppdatering | 01 May 2026 |
Senaste uppdateringar av tidigare prestationer
Recent updates
CL: 2030 Plan Execution And Margins Will Shape 2026 Setup
Analysts have trimmed the Colgate-Palmolive fair value estimate by about $0.58 to $96.68, reflecting slightly softer revenue growth assumptions, a modestly lower future P/E, and mixed recent research that includes both reduced price targets and an upgrade tied to confidence in the 2030 plan and ongoing margin resilience. Analyst Commentary Recent Street research on Colgate-Palmolive shows a mix of optimism around the long-term plan and caution around nearer term cost and valuation risks.CL: 2030 Plan And Emerging Markets Execution Will Shape 2026 Setup
Colgate-Palmolive's fair value estimate edges up to $97.26 from $97.21 as analysts lift price targets toward the $100 to $105 range, citing stronger confidence in the 2030 plan, product innovation, and emerging markets execution. Analyst Commentary Recent Street research on Colgate-Palmolive clusters around higher price targets and upgraded ratings, with the fair value conversation increasingly framed around the 2030 plan, execution in emerging markets, and portfolio moves such as the exit from private label pet food.Colgate-Palmolive: 2026 Guidance Is Conservative, But That Doesn't Make It A Buy
Mar 18CL: 2030 Plan And Emerging Markets Support Measured 2026 Execution Setup
Analysts have nudged their price expectations for Colgate-Palmolive higher, with the updated fair value estimate moving from about $96.68 to roughly $97.21. They cite growing confidence in the company’s 2030 plan, product innovation efforts and emerging markets exposure, as reflected in a series of recent price target increases across major firms.CL: 2030 Plan And Emerging Markets Will Drive Balanced 2026 Setup
Analysts have raised their implied price target for Colgate-Palmolive by about $8 to reflect higher conviction in the company’s 2030 plan, product innovation pipeline and emerging market exposure, as well as refreshed views on sector valuations. Analyst Commentary Recent research has centered on how Colgate-Palmolive’s 2030 plan, product pipeline and emerging market footprint feed into both growth potential and current valuation.There May Be Some Bright Spots In Colgate-Palmolive's (NYSE:CL) Earnings
Feb 06
CL: Emerging Markets And 2026 Setup Will Shape Balanced Risk Reward
Analysts have nudged their price targets for Colgate-Palmolive higher, reflected in a modest fair value move from about $87.47 to $88.89. They are factoring in slightly stronger revenue growth assumptions, a marginally higher future P/E and recent rating and target changes across firms such as Barclays, JPMorgan, UBS, Wells Fargo, Piper Sandler and TD Cowen.CL: Emerging Markets And 2026 Setup Support Balanced Outlook After Recent Softness
Our updated analyst price target for Colgate-Palmolive edges up to about US$87.47 from roughly US$87.21, as analysts balance slightly softer modeled revenue growth with modestly higher profit margin and future P/E assumptions. This view is supported by recent research that pairs cautious consumer staples outlooks with a more positive stance on the company’s emerging markets exposure and potential 2026 acceleration.CL: Emerging Market Strength Will Support Gradual Recovery As Q3 Softness Fades
Analysts have trimmed their price target on Colgate-Palmolive to $87 from the low-to-mid $90s, reflecting near term softness in Q3 results and muted personal care growth, even as they expect organic sales momentum to gradually improve. Analyst Commentary Analysts remain divided on Colgate-Palmolive, with recent target cuts reflecting near term execution risk, while longer term growth and margin recovery expectations stay largely intact.CL: Gradual Recovery Expected As Temporary Headwinds Ease In Personal Care Markets
Narrative Update on Colgate-Palmolive Colgate-Palmolive's analyst price target has been modestly reduced by $0.05 to $87.21. Analysts cite near-term growth challenges and muted sector outlooks following a soft Q3, but expect gradual improvement as temporary pressures ease.CL: Organic Sales Momentum Will Rebound As Near-Term Headwinds Ease
Colgate-Palmolive's analyst consensus price target was revised downward from approximately $88.84 to $87.26. Analysts cite a soft third quarter, moderated growth expectations, and ongoing category headwinds as key factors behind the adjustment.CL: Future Cost Optimization Will Drive Competitive Advantage Amid Category Headwinds
Colgate-Palmolive’s fair value estimate has been reduced from $90.74 to $88.84 per share. Analysts cite persistent category headwinds and a moderated sales outlook as factors behind lower price targets across the sector.Emerging Markets And Digital Transformation Will Unlock Global Value
Colgate-Palmolive's analyst fair value price target has decreased from $93.11 to $90.74. Analysts cite lowered sales guidance, persistent category headwinds, and muted growth outlooks as key factors behind their revised estimates.Emerging Markets And Digital Transformation Will Unlock Global Value
Colgate-Palmolive's analyst price target has been revised downward by approximately $2 to $93. Analysts cite ongoing category headwinds and decelerating growth in the personal care sector as reasons for this adjustment.There's Reason For Concern Over Colgate-Palmolive Company's (NYSE:CL) Price
Sep 30Colgate-Palmolive Company (NYSE:CL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 04
Colgate-Palmolive (NYSE:CL) Has A Pretty Healthy Balance Sheet
Jun 27Do Colgate-Palmolive's (NYSE:CL) Earnings Warrant Your Attention?
Jun 12The Trend Of High Returns At Colgate-Palmolive (NYSE:CL) Has Us Very Interested
May 15A Historic Brand, A Fresh Approach: Inside Colgate-Palmolive's Machine
Apr 22Colgate-Palmolive: A Defensive Stock With Growth Potential
Mar 20Is Colgate-Palmolive Quietly Building The Next Pet Food Empire?
Mar 14Colgate-Palmolive: Don't Get Your Hopes Up (Yet)
Feb 25Colgate-Palmolive Stock: Post-Earnings Drop Isn't A Buy-The-Dip Moment
Jan 31Colgate-Palmolive: Digital Advertising Is The Base From Which To Start Again
Dec 17Colgate-Palmolive: Approaching Buy Territory With Some Important Catalysts
Dec 11Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now
Oct 25Colgate-Palmolive: Very Close To A Buy Following Recent Pullback
Oct 17Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)
Sep 30Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Aug 19Colgate-Palmolive: Good Growth Prospects Ahead
Aug 06Fördelning av intäkter och kostnader
Hur Colgate-Palmolive tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.
Resultat- och intäktshistorik
| Datum | Intäkter | Intäkter | G+A Kostnader | FoU-kostnader |
|---|---|---|---|---|
| 31 Dec 25 | 20,382 | 2,132 | 7,887 | 0 |
| 30 Sep 25 | 20,097 | 2,908 | 7,798 | 0 |
| 30 Jun 25 | 19,998 | 2,908 | 7,805 | 0 |
| 31 Mar 25 | 19,947 | 2,896 | 7,778 | 0 |
| 31 Dec 24 | 20,101 | 2,889 | 7,810 | 0 |
| 30 Sep 24 | 20,106 | 2,868 | 7,720 | 0 |
| 30 Jun 24 | 19,989 | 2,840 | 7,557 | 0 |
| 31 Mar 24 | 19,752 | 2,611 | 7,390 | 0 |
| 31 Dec 23 | 19,457 | 2,300 | 7,244 | 0 |
| 30 Sep 23 | 19,136 | 1,587 | 7,058 | 0 |
| 30 Jun 23 | 18,676 | 1,497 | 6,870 | 0 |
| 31 Mar 23 | 18,338 | 1,598 | 6,749 | 0 |
| 31 Dec 22 | 17,967 | 1,785 | 6,645 | 0 |
| 30 Sep 22 | 17,741 | 1,928 | 6,596 | 0 |
| 30 Jun 22 | 17,700 | 1,944 | 6,599 | 0 |
| 31 Mar 22 | 17,476 | 2,044 | 6,514 | 0 |
| 31 Dec 21 | 17,421 | 2,166 | 6,477 | 0 |
| 30 Sep 21 | 17,342 | 2,665 | 6,512 | 0 |
| 30 Jun 21 | 17,081 | 2,729 | 6,396 | 0 |
| 31 Mar 21 | 16,718 | 2,661 | 6,225 | 0 |
| 31 Dec 20 | 16,471 | 2,695 | 6,093 | 0 |
| 30 Sep 20 | 16,162 | 2,691 | 5,865 | 0 |
| 30 Jun 20 | 15,937 | 2,571 | 5,756 | 0 |
| 31 Mar 20 | 15,906 | 2,522 | 5,725 | 0 |
| 31 Dec 19 | 15,693 | 2,367 | 5,616 | 0 |
| 30 Sep 19 | 15,489 | 2,330 | 5,536 | 0 |
| 30 Jun 19 | 15,406 | 2,275 | 5,486 | 0 |
| 31 Mar 19 | 15,426 | 2,326 | 5,412 | 0 |
| 31 Dec 18 | 15,544 | 2,400 | 5,434 | 0 |
| 30 Sep 18 | 15,625 | 2,117 | 5,442 | 0 |
| 30 Jun 18 | 15,754 | 2,201 | 5,472 | 0 |
| 31 Mar 18 | 15,694 | 2,088 | 5,478 | 0 |
| 31 Dec 17 | 15,454 | 2,024 | 5,412 | 0 |
| 30 Sep 17 | 15,283 | 2,307 | 5,289 | 0 |
| 30 Jun 17 | 15,176 | 2,402 | 5,195 | 0 |
| 31 Mar 17 | 15,195 | 2,478 | 5,185 | 0 |
| 31 Dec 16 | 15,195 | 2,441 | 5,172 | 0 |
| 30 Sep 16 | 15,373 | 2,461 | 5,213 | 0 |
| 30 Jun 16 | 15,505 | 2,485 | 5,232 | 0 |
| 31 Mar 16 | 15,726 | 2,459 | 5,296 | 0 |
| 31 Dec 15 | 16,034 | 2,468 | 5,400 | 0 |
| 30 Sep 15 | 16,356 | 2,470 | 5,548 | 0 |
| 30 Jun 15 | 16,736 | 2,286 | 5,700 | 0 |
Kvalitetsintäkter: CL har en stor engång förlust av $1.0B {1 månader till 31st December, 2025 1 månader) 31st December, 2025.
Växande vinstmarginal: CL s nuvarande netto vinstmarginaler (10.5%) är lägre än förra året (14.4%).
Fritt kassaflöde vs resultatanalys
Analys av tidigare vinsttillväxt
Resultatutveckling: CL s intäkter har ökat med 3.2% per år under de senaste 5 åren.
Accelererande tillväxt: CL s har haft negativ intäktstillväxt under det senaste året, så det kan inte jämföras med dess 5-åriga genomsnitt.
Resultat vs industri: CL hade negativ intäktstillväxt ( -26.2% ) under det senaste året, vilket gör det svårt att jämföra med branschens genomsnitt Household Products ( 3% ).
Avkastning på eget kapital
Hög ROE: Medan CL s avkastning på eget kapital ( 619.45% ) är utestående, är detta mått skevt på grund av deras höga skuldnivå.
Avkastning på tillgångar
Avkastning på sysselsatt kapital
Upptäck starka bolag som tidigare presterat bra
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/04/30 14:51 |
| Aktiekurs vid dagens slut | 2026/04/30 00:00 |
| Intäkter | 2025/12/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Colgate-Palmolive Company bevakas av 43 analytiker. 17 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Christopher Graja | Argus Research Company |
| Lauren Lieberman | Barclays |
| Lauren Lieberman | Barclays |